Skip to Main Content

Paper Details

LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial.
Eur J Prev Cardiol
34
2021
LDL-cholesterol, PCSK9, Women, atherosclerotic cardiovascular disease, cardiovascular death, evolocumab, men, myocardial infarction, patient, patients, statin, statins, stroke, unstable angina, women
Author NameAffiliation
Robert P GiuglianoBrigham and Women's Hospital and Harvard Medical School
Marc S SabatineBrigham and Women's Hospital and Harvard Medical School
Marc S SabatineBrigham and Women's Hospital and Harvard Medical School
  • 1 - 3

Datasets

Release 1.2